Список литературы
1. Wagner JC, Moncrieff CB, Coles R, Griffiths DM and Munday DE (1986). Correlation between fiber content of the lungs and disease in naval dockyard workers. Br J Indust Med 43: 391-395.
2. Mossman BT, Churg A: Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med 1998; 157: 1666-1680.
3. McFadden D, Wright JL, Wiggs B, Churg A: Cigarette smoke increases the penetration of asbestos fibers into airway walls. Am J Pathol 1986; 123: 95-99.
4. McFadden D, Wright JL, Wiggs B, Churg A. Smoking inhibits asbestos clearance. Amer Rev Respir Dis 1986; 133: 372-374.
5. Saracci R: Asbestos and lung cancer: an analysis of the epidemiological evidence on the asbestos-smoking interaction. Intl J Cancer 1977; 20: 323-331.
6. Berry G, Newhouse ML, Antonis P: Combined effect of asbestos and smoking on mortality from lung cancer and mesothelioma in factory workers. Br J Indust Med 1985; 42: 12-18.
7. Liddell FDK: The interaction of asbestos and smoking in lung cancer. Ann Occup Hyg 2001; 45(5): 341-356.
8. Liddell FDK, Armstrong BG: The combination of effects on lung cancer of cigarette smoking and exposure in Quebec chrysotile miners and millers. Ann Occup Hyg 2002; 46(1): 5-13.
9. McDonald JC, McDonald AD: Chrysotile, tremolite and carcinogencity. Ann Occup Hyg 1997; 41(6): 699-705.
10. Yarborough CM: Chrysotile as a cause of mesothelioma: an assessment based on epidemiology. Clin Rev Toxicol 2006; 36: 165-187.
11. Paustenbach DJ, Finley BL, Lu ET, Brorby GP, Sheehan PJ: Environmental and Occupational Health Hazards Associated with the Presence of Asbestos in Brake Linings and Pads (1900 to present): A «State-of-the-Art» Review. J Toxicol Environ Hlth, Part B 2004; 7: 33–110.
12. Ilgren E, Chatfield E: Coalinga Fiber - A Short, Amphibole-Free Chrysotile. Part 2: Evidence for lack of tumourigenic activity. Indoor Built Environ 1998; 7(1): 18-31.
13. Castleman BI: Scientific objectivity and the chrysotile controversy (letter). Occup and Environ Med 1994; 51(6): 431.
14. Smith AH and Wright CC: Chrysotile asbestos is the main cause of pleural mesothelioma. Am J Indust Med 1996; 30: 252-266.
15. Landrigan PJ, Nicholson WJ, Suzuki Y, Ladou J: The hazards of chrysotile asbestos: a critical review. Ind Health 1999 Jul; 37(3): 271-80.
16. WHO: Asbestos: In: WHO Air Quality Guidelines for Europe. WHO Regional Publications, European Series No. 23, World Health Organisation, Copenhagen, pp. 182-199 (1987).
17. WHO: International Programme on Chemical Safety Environmental Health Criteria 53 Asbestos and other natural mineral fibers. WHO Geneva (1986).
18. Finkelstein MM: Radiographic asbestosis is not a prerequisite for asbestos-associated lung cancer in Ontario asbestos-cement workers. Am J Indust Med 1997; 32(4): 341-348.
19. Case BW, Dufresne A: Asbestos, asbestosis and lung cancer: observations in Quebec chrysotile workers. Environ Hlth Perspect 1997; 105, suppl. 5: 1113-1119.
20. Weiss W: Asbestosis: a marker for the increased risk of lung cancer among workers exposed to asbestos. Chest 1999; 115(2): 536-549.
21. Churg A, Wright JL, Vedal S: Fiber burden and patterns of asbestos-related disease in chrysotile miners and millers. American Review of Respiratory Disease 1993; 148: 25-31.
22. Davis JMG, Addison J, McIntosh C, Miller BG, Niven K: Variations in the carcinogenicity of tremolite dust samples of differing morphology. Ann NY Acad Sci 1991; 643: 473-490.
23. Mumpton FA, Thompson CS: Mineralology of the Coalinga asbestos deposit. Research report 65-50, Union Carbide Corp., Niagara Falls, USA (1965).
24. Ilgren E, Chatfield E: Coalinga Fiber - A Short, Amphibole-Free Chrysotile. Part 1: Evidence for lack of fibrogenic activity. Indoor Built Environ 1997; 6: 264 - 276.
25. Ilgren EB: Coalinga Chrysotile: A Short Fiber, Amphibole Free, Chrysotile: Part V – Lack of Amphibole Asbestos Contamination Indoor Built Environ 2004; 13: 325–341.
26. Churg A,Vedal S: Fiber burden and patterns of asbestos-related disease in workers with heavy mixed amosite and chrysotile exposure. American Journal of Respiratory and Critical Care Medicine 1994; 150: 663-669.
27. Friedrichs KH, Brockmann M, Fischer M, Wick G: Electron-Microscopy Analysis of Mineral Fibers in Human Lung-Tissue. Amer J Indust Med 1992; 22 (1): 49-58.
28. Ontario Royal Commission. Report on matters of health and safety arising from the use of asbestos in Ontario. Toronto, Ontario, Ministry of the Attorney General, vols. 1-3, 1984.
29. Doll R, Peto J: Effects on Health of exposure to asbestos. Health and Safety Commission, HMSO, London (1985).
30. Churg A: Lung asbestos content in long-term residents of a chrysotile minsing town. Am Rev Respir Dis 1986; 134: 125-127.
31. Peto J, Doll R, Hermon C, Binns W, Clayton R, Goffe T: Relationship of mortality to measures of environmental asbestos pollution in an asbestos textile factory. Ann Occup Hyg 1985; 29: 305-355.
32. Calabrese EJ, the BELLE Advisory Committee: Biological effects of low level exposure. Human Exp Toxicol 1996; 15: 67-70.
33. Ames BN, Gold LS: Chemical carcinogenesis: too many rodent carcinogens. Proc Natl Acad Sci USA 1990; 87: 7772-7776.
34. Zapp JA: An acceptable level of exposure. Amer Indust Hyg Assoc J 1977; 38: 426.
35. Abelson PH: Risk assessments of low-level exposure (editorial). Science 1994; 265: 1507.
36. Albert RE: Carcinogen Risk assessment in the US Environmental Protection Agency Crit Rev Toxicol 1994; 24: 75-85.
37. BELLE: Is there a need for a new cancer risk assessment paradigm? (and associated articles). BELLE Newsletter 1996; 5: 1-20.
38. Osborne RV: A Cautionary Tale. J Radiol Prot 2006; 26: 253-255.
39. Wan KC: Nonscience or Nonsense in Occupational Health J Occup Health (Japan) 1996; 38: 89-93.
40. Tubiana M, Aurengo A, Averbeck D, Masse R: The debate on the use of linear no threshold for assessing the effects of low doses. J Radiol Prot 2006; 26: 317-324.
41. Spurny KR: On the emission of fibrous particles from weathered and corroded asbestos-cement products. Environ Res 1989; 48, 110-116.
42. Marconi A, Cecchetti G, Barbieri M: Airborne mineral fiber concentrations in an urban area near an asbestos cement plant. In: Non-Occupational Exposure to Mineral Fibers. Eds J Bignon,
J Peto and R Saracci IARC Lyon Scientific Publication № 90, pp 336-346 (1989).
43. Churg A, Wright JL: Persistence of natural mineral fibres in human lungs: an overview. Environ Hlth Perspect 1994; 102, suppl. 5: 229-233.
44. Friedrichs KH, Teschler H, Wick G, Konietzko N, Costabel U: Asbestos Content in Bronchoalveolar Lavage Fluids. Zentralblatt für Hygiene und Umweltmedizin 1991; 192 (4): 336-343.
45. Churg, A: Chrysotile, Tremolite and Malignant Mesothelioma in Man. Chest 1988; 93: 621-628.
46. Churg, A: Deposition and clearance of chrysotile asbestos. Ann Occup Hyg 1994; 38: 625-634.
47. Camus M, Siemiatycki J, Case BW, Désy M, Richardson L, Campbell S: Risk of Mesothelioma Among Women Living Near Chrysotile Mines Versus US EPA Asbestos Risk Model: Preliminary Findings. Ann Occup Hyg 2002; 46 (Suppl 1): 95–98.
48. Gardner MJ, Saracci R: Effects on health of non- occupational exposure to airborne mineral fibers. In Non-occupational exposure to mineral fibers. Eds J Bignon, J Peto and R Saracci IARC Lyon Scientific Publication № 90, pp 375-397 (1989).
49. Bernstein DM, Hoskins JA: The health effects of chrysotile: Current perspective based upon recent data. Regulatory Toxicol Pharmacol 2006; 45: 252–264.
50. Davis JMG: Mineral fiber carcinogenesis: experimental data relating to the importance of fiber type, size, deposition, dissolution and migration. In: Non-Occupational Exposure to Mineral Fibers. Intl Agency for Research on Cancer (editors, Bignon J, Peto J and Saracci R) 1989; 90: 33-43.
51. Davis JM and Jones A: Comparisons of the pathogenicity of long and short fibers of chrysotile asbestos in rats. Br J Еxp Path 1988; 69: 717-737.
52. Hughes JM, Weill H: Asbestos exposure – quantitative assessment of risk. Am Rev Respir Dis 1986; 133: 5-13.
53. Valleron A-J, Bignon J, Hughes JM, Hesterberg TM, Schneider T, Burdett GJ, Brochard P, Hémon D: Low dose exposure to natural and man made fibres and the risk of cancer: toward a collaborative European epidemiology. Br J Indust Med 1992; 49: 606-614.
54. Lash TL, Crouch EAC, Green LC: A meta-analysis of the relation between cumulative exposure to asbestos and relative risk of lung cancer. Occup Environ Med 1997; 54: 254-263.
55. Browne K: Asbestos related malignancy and the Cairns hypothesis. Br J Indust Med 1991; 48: 73-76.
56. Berman DW, Crump, KS: Draft technical support document for a protocol to assess asbestos-related risk. Washington, DC 20460: Office of Solid Waste and Emergency Response U.S. Environmental Protection Agency (2003).
57. McClellan RO: Health Risk Assessment and Regulatory Considerations for Air Pollutants. In: Air Pollutants and the Respiratory Tract. (Swift DL, Foster WM (eds.)) Marcel Dekker, New York (1999), pp 289-338.
58. Carel R, Olsson AC, Zaridze D, Szeszenia-Dabrowska N, Rudnai P, Lissowska J, Fabianova, E Cassidy A, Mates D, Bencko V, Foretova L, Janout V, Fevotte J, Fletcher T, Mannetje A, Brennan P, Boffetta P: Occupational exposure to asbestos and man-made vitreous fibres and risk of lung cancer: a multicenter case-control study in Europe. Occup Environ Med 2006, published online 19 Oct 2006; doi:10.1136/oem.2006.027748.
59. Ames BN, Shigenaga MK, Gold LS: DNA lesions, inducible DNA repair and cell division: three key factors in mutagenesis and carcinogenesis. Environ Health Perspect 1993; 101 (suppl. 5): 35-44.
60. Abelson PH: The asbestos removal fiasco (editorial). Science 1990; 247: 1017.
61. Burdett GJ, Jaffrey SAMT, Rood AP: Airborne asbestos fiber levels in buildings: a summary of UK measurements. In: «Non-Occupational Exposure to Mineral Fibers». Eds J Bignon, J Peto and R Saracci, IARC Lyon Scientific Publication № 90, pp 277-290 (1989).
62. Asbestos Watchdog: http://www.asbestoswatchdog.co.uk (2006).
|
